talquetamab
janssen
['talquetamab', 'multiplemyeloma']
#talquetamab had substantial antitumor effects in patients with heavily pretreated relapsed or refractory #multiplemyeloma, reported at #ash22. the current data is "quite exciting," said . 
Follow for #oncology news and coverage of all major oncology meetings! Peer-reviewed and oncologist-trusted.

@MedPageToday | #OncTwitter